BioHarvest Sciences (BHST) Competitors $5.55 +0.15 (+2.78%) As of 03:54 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock BHST vs. ORIC, KMDA, PHAT, ABVX, ERAS, RAPP, UPB, ALT, VERV, and STOKShould you be buying BioHarvest Sciences stock or one of its competitors? The main competitors of BioHarvest Sciences include ORIC Pharmaceuticals (ORIC), Kamada (KMDA), Phathom Pharmaceuticals (PHAT), ABIVAX Société Anonyme (ABVX), Erasca (ERAS), Rapport Therapeutics (RAPP), Upstream Bio (UPB), Altimmune (ALT), Verve Therapeutics (VERV), and Stoke Therapeutics (STOK). These companies are all part of the "pharmaceutical products" industry. BioHarvest Sciences vs. ORIC Pharmaceuticals Kamada Phathom Pharmaceuticals ABIVAX Société Anonyme Erasca Rapport Therapeutics Upstream Bio Altimmune Verve Therapeutics Stoke Therapeutics BioHarvest Sciences (NASDAQ:BHST) and ORIC Pharmaceuticals (NASDAQ:ORIC) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, valuation, dividends, profitability, risk, earnings, analyst recommendations, institutional ownership and community ranking. Do analysts rate BHST or ORIC? BioHarvest Sciences currently has a consensus target price of $13.00, indicating a potential upside of 140.74%. ORIC Pharmaceuticals has a consensus target price of $18.86, indicating a potential upside of 302.07%. Given ORIC Pharmaceuticals' higher probable upside, analysts plainly believe ORIC Pharmaceuticals is more favorable than BioHarvest Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioHarvest Sciences 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00ORIC Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media refer more to BHST or ORIC? In the previous week, BioHarvest Sciences had 9 more articles in the media than ORIC Pharmaceuticals. MarketBeat recorded 11 mentions for BioHarvest Sciences and 2 mentions for ORIC Pharmaceuticals. BioHarvest Sciences' average media sentiment score of 1.21 beat ORIC Pharmaceuticals' score of 0.84 indicating that BioHarvest Sciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BioHarvest Sciences 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive ORIC Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community favor BHST or ORIC? ORIC Pharmaceuticals received 69 more outperform votes than BioHarvest Sciences when rated by MarketBeat users. However, 100.00% of users gave BioHarvest Sciences an outperform vote while only 75.00% of users gave ORIC Pharmaceuticals an outperform vote. CompanyUnderperformOutperformBioHarvest SciencesOutperform Votes3100.00% Underperform VotesNo VotesORIC PharmaceuticalsOutperform Votes7275.00% Underperform Votes2425.00% Do institutionals & insiders hold more shares of BHST or ORIC? 95.1% of ORIC Pharmaceuticals shares are held by institutional investors. 5.6% of ORIC Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Is BHST or ORIC more profitable? ORIC Pharmaceuticals has a net margin of 0.00% compared to BioHarvest Sciences' net margin of -76.65%. BioHarvest Sciences' return on equity of 0.00% beat ORIC Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets BioHarvest Sciences-76.65% N/A -85.16% ORIC Pharmaceuticals N/A -44.54%-40.72% Which has stronger valuation and earnings, BHST or ORIC? BioHarvest Sciences has higher revenue and earnings than ORIC Pharmaceuticals. BioHarvest Sciences is trading at a lower price-to-earnings ratio than ORIC Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioHarvest Sciences$25.19M3.52-$12.56M-$0.72-7.50ORIC PharmaceuticalsN/AN/A-$100.70M-$1.82-2.58 Which has more volatility and risk, BHST or ORIC? BioHarvest Sciences has a beta of 0.84, indicating that its share price is 16% less volatile than the S&P 500. Comparatively, ORIC Pharmaceuticals has a beta of 1.38, indicating that its share price is 38% more volatile than the S&P 500. SummaryORIC Pharmaceuticals beats BioHarvest Sciences on 9 of the 16 factors compared between the two stocks. Remove Ads Get BioHarvest Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for BHST and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BHST vs. The Competition Export to ExcelMetricBioHarvest SciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$88.70M$6.27B$5.29B$7.60BDividend YieldN/A2.98%5.35%4.27%P/E Ratio-4.326.8322.2218.06Price / Sales3.52200.79356.5190.67Price / CashN/A65.6738.1534.64Price / Book-5.005.646.273.95Net Income-$12.56M$140.88M$3.19B$247.18M7 Day Performance-5.92%0.22%-1.21%0.06%1 Month Performance1.31%-10.02%-0.32%-5.03%1 Year PerformanceN/A-17.16%5.17%-3.63% BioHarvest Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BHSTBioHarvest SciencesN/A$5.55+2.8%$13.00+134.2%N/A$91.16M$25.19M-4.44N/AAnalyst ForecastAnalyst RevisionNews CoveragePositive NewsHigh Trading VolumeORICORIC Pharmaceuticals3.8402 of 5 stars$4.88-7.2%$18.86+286.4%-56.0%$346.61MN/A-2.6880Gap DownKMDAKamada3.5026 of 5 stars$5.99-4.6%$14.67+144.9%+13.8%$344.31M$160.95M21.39360PHATPhathom Pharmaceuticals3.0323 of 5 stars$4.88-2.6%$22.17+354.2%-63.2%$339.83M$55.25M-0.86110Analyst ForecastGap DownABVXABIVAX Société Anonyme2.3841 of 5 stars$5.32-8.1%$38.00+614.3%-60.6%$337.20MN/A0.0061News CoveragePositive NewsGap DownERASErasca2.8204 of 5 stars$1.16-4.1%$4.83+316.7%-47.1%$328.59MN/A-1.40120Gap DownRAPPRapport Therapeutics1.7447 of 5 stars$8.99+5.5%$35.00+289.3%N/A$328.10MN/A-0.65N/AAnalyst ForecastNews CoverageGap DownUPBUpstream BioN/A$6.10-3.2%$56.50+826.2%N/A$327.21M$2.37M0.0038Lockup ExpirationNews CoverageGap DownALTAltimmune2.3752 of 5 stars$4.24-4.9%$20.83+391.4%-49.6%$326.54M$20,000.00-2.7450VERVVerve Therapeutics1.9025 of 5 stars$3.62-6.0%$20.67+470.9%-61.0%$321.44M$32.33M-1.47110Gap DownSTOKStoke Therapeutics3.0795 of 5 stars$5.94-5.7%$24.67+315.3%-50.0%$321.22M$36.56M-2.83100Analyst ForecastPositive NewsGap Down Remove Ads Related Companies and Tools Related Companies ORIC Pharmaceuticals Competitors Kamada Competitors Phathom Pharmaceuticals Competitors ABIVAX Société Anonyme Competitors Erasca Competitors Rapport Therapeutics Competitors Upstream Bio Competitors Altimmune Competitors Verve Therapeutics Competitors Stoke Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BHST) was last updated on 4/10/2025 by MarketBeat.com Staff From Our Partners6 stocks could soar on DOGE AI news …Stay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredThis almost killed Elon Musk (chilling details emerge)Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredElon’s ‘Strike Squad’ sends these 9 stocks soaring?Elon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the ...Altimetry | SponsoredNow that Trump’s be inaugurated, this day will be key (mark your calendar)Mark your calendar for May 7th. Because on that day, I believe we could see a $2 Trillion shock INTO the ma...Timothy Sykes | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioHarvest Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioHarvest Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BHST Stock Free BHST Stock Alerts